Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 5 |
2022 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The basis of a more contagious 501Y.V1 variant of SARS-CoV-2.
Cell Res. 2021 Jun;31(6):720-722. doi: 10.1038/s41422-021-00496-8. Epub 2021 Apr 23.
Cell Res. 2021.
PMID: 33893398
Free PMC article.
No abstract available.
The basis of a more contagious 501Y.V1 variant of SARS-COV-2.
Liu H, Zhang Q, Wei P, Chen Z, Aviszus K, Yang J, Downing W, Peterson S, Jiang C, Liang B, Reynoso L, Downey GP, Frankel SK, Kappler J, Marrack P, Zhang G.
Liu H, et al. Among authors: reynoso l.
bioRxiv [Preprint]. 2021 Feb 2:2021.02.02.428884. doi: 10.1101/2021.02.02.428884.
bioRxiv. 2021.
PMID: 33564771
Free PMC article.
Updated.
Preprint.
Item in Clipboard
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro.
Liu H, Wei P, Zhang Q, Chen Z, Aviszus K, Downing W, Peterson S, Reynoso L, Downey GP, Frankel SK, Kappler J, Marrack P, Zhang G.
Liu H, et al. Among authors: reynoso l.
MAbs. 2021 Jan-Dec;13(1):1919285. doi: 10.1080/19420862.2021.1919285.
MAbs. 2021.
PMID: 34074219
Free PMC article.
Item in Clipboard
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to Bamlanivimab in vitro.
Liu H, Wei P, Zhang Q, Chen Z, Aviszus K, Downing W, Peterson S, Reynoso L, Downey GP, Frankel SK, Kappler J, Marrack P, Zhang G.
Liu H, et al. Among authors: reynoso l.
bioRxiv [Preprint]. 2021 Feb 16:2021.02.16.431305. doi: 10.1101/2021.02.16.431305.
bioRxiv. 2021.
PMID: 33619479
Free PMC article.
Updated.
Preprint.
Item in Clipboard
The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines.
Liu H, Wei P, Zhang Q, Aviszus K, Linderberger J, Yang J, Liu J, Chen Z, Waheed H, Reynoso L, Downey GP, Frankel SK, Kappler J, Marrack P, Zhang G.
Liu H, et al. Among authors: reynoso l.
bioRxiv [Preprint]. 2021 Aug 26:2021.08.25.457692. doi: 10.1101/2021.08.25.457692.
bioRxiv. 2021.
PMID: 34462744
Free PMC article.
Updated.
Preprint.
Item in Clipboard
The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral Immunity.
Liu H, Wei P, Aviszus K, Zhang Q, Linderberger J, Yang J, Liu J, Chen Z, Waheed H, Reynoso L, Downey GP, Frankel SK, Kappler JW, Marrack P, Zhang G.
Liu H, et al. Among authors: reynoso l.
Int J Mol Sci. 2022 Sep 26;23(19):11325. doi: 10.3390/ijms231911325.
Int J Mol Sci. 2022.
PMID: 36232627
Free PMC article.
Item in Clipboard
Cite
Cite